DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ACRIDINE CARBOXAMIDE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ACRIDINE CARBOXAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATIDEGIB HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PATIDEGIB HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
ZL14FCA5PK
Molecule Type:
Small molecule
Molecular Formula:
C29H49ClN2O3S
Molecular Weight:
541.24
AlogP:
5.03
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
2.0
Source:
KRN5500
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neuralgia
Unknown
KRN5500
×
Maximum Phase:
2
First Approval:
None
UNII:
8VH13L5K20
Molecule Type:
Small molecule
Molecular Formula:
C28H43N7O7
Molecular Weight:
589.69
AlogP:
0.42
PSA:
214.84
HBD:
8.0
HBA:
#RotB:
17.0
Source:
FLUMATINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tyrosine-protein kinase ABL inhibitor
FLUMATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
R4009Y24AI
Molecule Type:
Small molecule
Molecular Formula:
C29H29F3N8O
Molecular Weight:
562.6
AlogP:
5.0
PSA:
99.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RING SCAN 111IN
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RING SCAN 111IN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CACP29
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CACP29
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-8852
2
Unknown
Investigational
Unknown
Unknown
Influenza, Human
Hemagglutinin binding agent
MEDI-8852
×
Maximum Phase:
2
First Approval:
None
UNII:
OZS4TXB9VO
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RELMAPIRAZIN
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Unknown
RELMAPIRAZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3UQB8PQ6H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N6O8
Molecular Weight:
372.29
AlogP:
-4.01
PSA:
251.08
HBD:
8.0
HBA:
#RotB:
8.0
Source:
NT-501
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NT-501
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HER-2
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HER-2
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LATIGLUTENASE
2
Enzyme
Investigational
Unknown
Unknown
Celiac Disease
Unknown
LATIGLUTENASE
×
Maximum Phase:
2
First Approval:
None
UNII:
090PL12YZJ
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
T-2000
2
Small molecule
Investigational
Unknown
Unknown
Essential Tremor
Unknown
T-2000
×
Maximum Phase:
2
First Approval:
None
UNII:
QW2J7VST60
Molecule Type:
Small molecule
Molecular Formula:
C20H20N2O5
Molecular Weight:
368.39
AlogP:
1.97
PSA:
76.15
HBD:
0.0
HBA:
#RotB:
6.0
Source:
JNJ-54861911
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-54861911
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AURICLOSENE
2
Small molecule
Investigational
Unknown
Unknown
Conjunctivitis, Bacterial; Conjunctivitis, Viral; Impetigo
Unknown
AURICLOSENE
×
Maximum Phase:
2
First Approval:
None
UNII:
BKR7Y95229
Molecule Type:
Small molecule
Molecular Formula:
C4H9Cl2NO3S
Molecular Weight:
222.09
AlogP:
1.26
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BRILACIDIN TETRAHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BRILACIDIN TETRAHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
CM3HYX69SK
Molecule Type:
Small molecule
Molecular Formula:
C40H54Cl4F6N14O6
Molecular Weight:
1082.76
AlogP:
3.68
PSA:
308.5
HBD:
12.0
HBA:
#RotB:
20.0
Source:
LETETRESGENE AUTOLEUCEL
2
Gene
Investigational
Unknown
Unknown
Neoplasms
Unknown
LETETRESGENE AUTOLEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
B5ME4ZU4BS
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISTIRATUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Pancreatic Neoplasms
Insulin-like growth factor I receptor inhibitor
ISTIRATUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
XLR461MD3M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Z160
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Radiculopathy
Voltage-gated N-type calcium channel alpha-1B subunit blocker
Z160
×
Maximum Phase:
2
First Approval:
None
UNII:
TX3R141LEP
Molecule Type:
Small molecule
Molecular Formula:
C32H32N2O
Molecular Weight:
460.62
AlogP:
6.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
RECIFERCEPT
2
Protein
Investigational
Unknown
Unknown
Achondroplasia
Unknown
RECIFERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIBINETIDE
2
Protein
Investigational
Unknown
Unknown
Depressive Disorder
Unknown
CIBINETIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
9W5677JKDA
Molecule Type:
Protein
Molecular Formula:
C51H84N16O21
Molecular Weight:
1257.32
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRU-015
2
Unknown
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic; Lymphoma; Arthritis, Rheumatoid
B-lymphocyte antigen CD20 binding agent
TRU-015
×
Maximum Phase:
2
First Approval:
None
UNII:
T0N62K2M2Y
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOXAVERINE
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Ischemia
Unknown
MOXAVERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P3P08Y1XJ4
Molecule Type:
Small molecule
Molecular Formula:
C20H21NO2
Molecular Weight:
307.39
AlogP:
4.41
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TRIGONELLAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Hyperlipidemias
Unknown
TRIGONELLAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UM47085BXC
Molecule Type:
Small molecule
Molecular Formula:
C7H9N2O+
Molecular Weight:
137.16
AlogP:
-0.39
PSA:
46.97
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PM-00104
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Endometrial Neoplasms; Uterine Cervical Neoplasms
Unknown
PM-00104
×
Maximum Phase:
2
First Approval:
None
UNII:
C21EZR41AY
Molecule Type:
Small molecule
Molecular Formula:
C37H38F3N3O8
Molecular Weight:
709.72
AlogP:
4.72
PSA:
130.03
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ZAGOTENEMAB
2
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease
Microtubule-associated protein tau inhibitor
ZAGOTENEMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AY6V5E2GNX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAT-203
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CAT-203
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD0328
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
AZD0328
×
Maximum Phase:
2
First Approval:
None
UNII:
2B218X5QIY
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
FGF401
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 4 inhibitor
FGF401
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMX-010
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Acne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
Unknown
BMX-010
×
Maximum Phase:
2
First Approval:
None
UNII:
BN93L2NT5I
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NRX194204
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NRX194204
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DS107G
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DS107G
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APILIMOD MESYLATE
2
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Crohn Disease
1-phosphatidylinositol 3-phosphate 5-kinase inhibitor
APILIMOD MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5G3P5OK11S
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MERIMEPODIB
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Inosine-5'-monophosphate dehydrogenase 1 inhibitor
MERIMEPODIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZL2BA06FU
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O6
Molecular Weight:
452.47
AlogP:
4.01
PSA:
123.95
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DORAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
MAP kinase p38 alpha inhibitor
DORAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HO1A8B3YVV
Molecule Type:
Small molecule
Molecular Formula:
C31H37N5O3
Molecular Weight:
527.67
AlogP:
5.99
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TAT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
140
141
142
143
144
145
146
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA